triumph-1 trial retatrutide ⭐️topline results from TRIUMPH-1, a Phase 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesity or “overweight” The clinical program involving the

Your data will thank you for it

Thus, GLP-1RAs play an underlying role in immune-regulation in T1DM (Figure 2)

Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility JANUMET XR No animal studies have been conducted with the combined products in JANUMET XR to evaluate carcinogenesis, mutagenesis or impairment of fertility

Important safety information: Retatrutide is an investigational medication that hasnt been approved by the MHRA, FDA, or any other regulator as of May 2026

Correcting metabolic and nutritional triggers remains the primary intervention

A short history of GLP-1s In 1987, researchers discovered a hormone derived from the gut that supported insulin release to manage blood sugar levels known as glucagon-like peptide 1 (GLP-1)